Roberta Brocardo - Theradiag Ex Officer
| ALTHE Stock | EUR 0.21 0.01 4.55% |
Insider
Roberta Brocardo is Ex Officer of Theradiag SA
| Phone | 33 1 55 48 90 70 |
| Web | https://www.theraclion.com |
Theradiag Management Efficiency
The company has return on total asset (ROA) of (0.2533) % which means that it has lost $0.2533 on every $100 spent on assets. This is way below average. Theradiag's management efficiency ratios could be used to measure how well Theradiag manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | INSIDER Age | ||
| Benoit Canolle | Biophytis SA | 45 | |
| Nicolas Reymond | Intrasense | 41 | |
| Khalil Filali | Intrasense | N/A | |
| FFPM MBA | Biophytis SA | 52 | |
| Thomas Lamy | Biosynex | N/A | |
| Jacques Martin | Eurobio Scientific SA | N/A | |
| Thomas Iff | Eurobio Scientific SA | N/A | |
| Philippe Rousseau | Biophytis SA | 52 | |
| Lionel Seltz | Intrasense | N/A | |
| Denis Fortier | Eurobio Scientific SA | 55 | |
| Herve MBA | Eurobio Scientific SA | 64 | |
| JeanMichel Grandmougin | Eurobio Scientific SA | 62 | |
| Jeremy Peyron | Intrasense | N/A | |
| Teylan | Biophytis SA | N/A | |
Management Performance
| Return On Asset | -0.25 |
Theradiag SA Leadership Team
Elected by the shareholders, the Theradiag's board of directors comprises two types of representatives: Theradiag inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theradiag. The board's role is to monitor Theradiag's management team and ensure that shareholders' interests are well served. Theradiag's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theradiag's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yann Duchesne, Ex Chairman | ||
| Roberta Brocardo, Ex Officer | ||
| Jose AbellanMartinez, VP Devel | ||
| Anja Kleber, VP Access | ||
| David Auregan, Chief Officer | ||
| Gaylord Tallec, Director Operations | ||
| Michel MD, VP Officer |
Theradiag Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Theradiag a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.25 | |||
| Operating Margin | (8.41) % | |||
| Current Valuation | 20.58 M | |||
| Shares Outstanding | 28.8 M | |||
| Shares Owned By Insiders | 22.50 % | |||
| Shares Owned By Institutions | 7.88 % | |||
| Price To Book | 10.04 X | |||
| Price To Sales | 34.41 X | |||
| Revenue | 1.48 M | |||
| Gross Profit | (1.4 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Theradiag Stock Analysis
When running Theradiag's price analysis, check to measure Theradiag's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theradiag is operating at the current time. Most of Theradiag's value examination focuses on studying past and present price action to predict the probability of Theradiag's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theradiag's price. Additionally, you may evaluate how the addition of Theradiag to your portfolios can decrease your overall portfolio volatility.